Standout Papers

Efficacy and safety of ge... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
    2022 174 citations Lorcan McGarvey, Surinder S. Birring et al. The Lancet profile →

Immediate Impact

10 hit
Sub-graph 1 of 5

Citing Papers

Diabetic neuropathy: cutting-edge research and future directions
2025 Hit
Interstitial Lung Disease
2024 Hit
3 intermediate papers

Works of David Muccino being referenced

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2022 Hit
Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough
2022
and 3 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Muccino 400 346 120 84 42 27 471
Rayid Abdulqawi 360 0.9× 272 0.8× 59 0.5× 57 0.7× 77 1.8× 27 478
Huda Badri 411 1.0× 351 1.0× 74 0.6× 85 1.0× 5 0.1× 19 478
Li Yu 383 1.0× 268 0.8× 86 0.7× 170 2.0× 4 0.1× 55 453
S. Redfors 179 0.4× 195 0.6× 21 0.2× 89 1.1× 3 0.1× 26 488
Renata Péčová 377 0.9× 299 0.9× 52 0.4× 73 0.9× 37 457
Kristof Raemdonck 214 0.5× 279 0.8× 30 0.3× 7 0.1× 23 0.5× 16 502
C Bernard 39 0.1× 170 0.5× 21 0.2× 351 4.2× 3 0.1× 22 543
Herbert J. Movius 158 0.4× 44 0.1× 55 0.5× 113 1.3× 1 0.0× 22 495
Matthew C. Koopmann 148 0.4× 68 0.2× 36 0.3× 22 0.3× 1 0.0× 28 540
João Antonio Gimenes-Júnior 110 0.3× 69 0.2× 54 0.5× 2 0.0× 5 0.1× 16 486

All Works

Loading papers...

Rankless by CCL
2026